To determine whether a 1-hour glucose screen done at 26 to 29 weeks' gestation that is below the fifth percentile is predictive of having a small for gestational age (SGA) infant.
Being small for gestational age (SGA) is a source of significant perinatal morbidity, long-term neonatal neurodevelopment disabilities, and even mortality. Growth restriction in the presence of maternal hypertension 1 or smoking 2 is thought to originate from vascular changes in the uteroplacental bed. However, the etiologies of delayed growth in the absence of hypertension or abnormal uteroplacental vascular architecture or flow are less understood. Many of the metabolic causes of unexplained growth restriction have not been fully delineated. We still lack the ability to accurately predict which pregnancies are at risk for being SGA during the antepartum period. Likewise, significant numbers of SGA fetuses are not diagnosed until the postpartum period.
It has been shown that maternal carbohydrate metabolism and anthropometric characteristics, such as pregravid weight and weight gain during pregnancy, correlate with neonatal birth weight. Catalano et al. 3 confirmed that maternal carbohydrate metabolism plays a role in fetal growth by showing that birth weight is inversely related to insulin sensitivity in normal and gestational diabetic pregnancies.
It is well established that maternal obesity and weight gain in pregnancy are associated with increased infant weight, and that maternal hyperglycemia is associated with macrosomia; however, much less information exists on the interaction between low maternal glucose levels and decreased infant weight. A few reports have observed that the maternal glucose and insulin plasma levels after an oral glucose tolerance test were lower in women with growth-restricted pregnancies than in women with normal pregnancies. 4 -7 These observations imply that maternal carbohydrate metabolism is involved in the pathogenesis of growth restriction, which is unexplained by vascular compromise.
Caruso et al. 8 prospectively studied maternal glucose tolerance and insulin sensitivity using the glucose tolerance test and hyperinsulinemic-euglycemic clamps technique. They concluded that women with unexplained fetal growth restriction exhibit a different glucose metabolic pattern than do women with normally grown fetuses. They speculated that increased insulin sensitivity leads to a reduction in metabolic substrates for fetal growth.
The purpose of our study was to determine whether there is an association between having an SGA infant and low 1-hour glucose screen values.
MATERIALS AND METHODS
This retrospective study made use of the Johns Hopkins Perinatal Database, which was searched for deliveries with a recorded 1-hour glucose screen. A total of 13,365 were identified for analysis.
Percentiles for the 1-hour glucose screen were established for our population and are listed in Table 1 . We defined a low glucose screen as one with a value of less than the fifth percentile (Ͻ71 mg/dl). Abell 9 similarly used less than the fifth percentile to describe a low glucose screen (Ͻ88 mg/dl in his population). Calfee et al., 10 based on Abell's initial study, 9 used a glucose screen of Ͻ88 mg/dl to define hypoglycemia in identifying a patient population to be followed pro-
spectively for poor perinatal outcomes. A total of 600 patients had low glucose screens and represent our cases. We defined a normal glucose screen as a value between the 25th and 75th percentiles. A total of 6784 patients had normal glucose screens and represent our control group. We used values between the 25th and 75th percentiles because these glucose screens represent a narrowly defined normal population.
Values between the 5th and 25th percentiles represent borderline low glucose screens and may include a mixture of some abnormal and normal values. Similarly, values between the 75th and 95th percentiles (borderline high) may include a combination of abnormal and normal values. Using the second and third quartiles of glucose screen values (25th to 75th percentiles) allows us to draw inferences from comparisons between our abnormal values and a set of values extracted from a definitively normal population. SGA was defined as a birth weight of less than the 10th percentile for gestational age and infant sex as defined by the national standard of Alexander et al. Statistical analysis was by Student's t-tests or Fisher's exact test where appropriate for univariate analysis. Logistic regression was used for multivariate analysis. Statistical significance was defined as a p value of Ͻ0.05.
RESULTS
Patients with low glucose screens had babies with smaller average birth weights and had more infants who were SGA ( Table 2 ). The groups were balanced for maternal prepregnancy body mass index (BMI), number of mothers with low prepregnancy BMI, pregnancy weight gain, and smoking status. The low glucose screen group contained more black patients; therefore, because black race is associated with low birth weight for gestational age, a logistic regression analysis was performed (Table 3) .
Using gestational age-and infant sex-specific standards for low birth weight and controlling for race, a low glucose screen remained an independent risk factor for giving birth to an SGA infant.
COMMENTS
By using 1-hour glucose screens, we identified a subgroup of patients with SGA fetuses whose growth restriction could not be attributed to known risk factors (i.e., smoking, race, low prepregnancy BMI, and low weight gain during pregnancy). In this subgroup, a low glucose screen of Ͻ71 mg/dl was an independent risk factor for giving birth to an SGA infant.
These findings are consistent with the speculation of Caruso et al. 8 that some women with growth-restricted fetuses may exhibit a greater peripheral insulin sensitivity than women with normally grown fetuses. The heightened maternal insulin sensitivity may induce a maternal competition for metabolic substrates, with increased glucose and calories being shunted to the mother, resulting in less energy being available for fetal growth.
Patients whose glucose screen placed them at less than the fifth percentile may constitute a subgroup of pregnant individuals who may benefit from increased surveillance for the development of SGA fetuses during both their index and future gestations. In contrast, Calfee et al. 10 reported that women with hypoglycemia defined as Ͻ88 mg/dl on their 1-hour glucose screens did not give birth to SGA infants. Therefore, two questions that future research specifically needs to address are: (1) are low 1-hour glucose screens truly associated with increased insulin sensitivity? and (2) will patients identified prospectively by low 1-hour glucose screens of Ͻ71 mg/dl (hypoglycemia in our cohort) actually give birth to SGA infants? 
